The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Nonfasting Plasma Total Homocysteine Levels and All-Cause and Cardiovascular Disease Mortality in Elderly Framingham Men and Women
Abstract
BACKGROUND: Elevated fasting total homocysteine (tHcy) levels were recently shown to confer an independent risk for all-cause and cardiovascular disease (CVD) mortality among selected Norwegian patients with confirmed coronary heart disease. We examined whether elevated fasting plasma tHcy levels were predictive of all-cause and CVD mortality in a large, population-based sample of elderly US women and men. METHODS: Nonfasting plasma tHcy levels were determined in 1933 elderly participants (mean age, 70 +/- 7 years; 58.9% women) from the original Framingham Study cohort, examined between 1979 and 1982, with follow-up through 1992. Unadjusted and adjusted (ie, for age, sex, diabetes, smoking, systolic blood pressure, total and high-density lipoprotein cholesterol, and creatinine) relative risk estimates (with 95% confidence intervals [CIs]) for total and CVD mortality were generated by proportional hazards modeling, with tHcy levels (quartiles) as the independent variable. RESULTS: There were 653 total deaths and 244 CVD deaths during a median follow-up of 10.0 years. Proportional hazards modeling revealed that tHcy levels of 14.26 micromol/L or greater (the upper quartile), vs less than 14.26 micromol/L (the lower three quartiles), were associated with relative risk estimates of 2.18 (95% CI, 1.86-2.56) and 2.17 (95% CI, 1.68-2.82) for all-cause and CVD mortality, respectively. The relative risk estimates after adjustment for age, sex, systolic blood pressure, diabetes, smoking, and total and high-density lipoprotein cholesterol levels attenuated these associations, but they remained significant: 1.54 (95% CI, 1.31-1.82) for all-cause mortality; 1.52 (95% CI, 1.16-1.98) for CVD mortality. CONCLUSION: Elevated nonfasting plasma tHcy levels are independently associated with increased rates of all-cause and CVD mortality in the elderly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972 · cited 1×
“Our data confirm that tHcy levels are increased in elderly persons.(9,18) Potential etiologic factors accounting for this age-related increase in tHcy levels include suboptimal intake and absorption of the key vitamin B cofactors or substrates for Hcy metabolism(18); reduced activity of Hcy-metabolizing enzymes (for e…”
BackgroundSelf-citationVascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.
Ks, M. (1969) · PubMed Central · Cited by 1,803
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
The natural history of homocystinuria due to cystathionine beta-synthase deficiency.
Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., Wilcken, B. M., Pyeritz, R. E., Andria, G., Boers, G. H. J., Bromberg, I. L., & Cerone, R. (1985) · PubMed · Cited by 1,256
Fried, L. P. (1998) · JAMA · doi:10.1001/jama.279.8.585 · Cited by 1,107
Total homocysteine in plasma or serum: methods and clinical applications
Ueland, P. M., Refsum, H., Stabler, S. P., Malinow, M. R., Andersson, A., & Allen, R. H. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.9.1764 · Cited by 981
The pathogenesis of coronary artery disease. A possible role for methionine metabolism.
Wilcken, D. E., & Wilcken, B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108350 · Cited by 529
Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
Lentz, S. R., Sobey, C. G., Piegors, D. J., Bhopatkar, M. Y., Faraci, F. M., Malinow, M. R., & Heistad, D. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118771 · Cited by 501
Bostom, A. G., & Lathrop, L. (1997) · Kidney International · doi:10.1038/ki.1997.298 · Cited by 456
Self-citation
Cited by
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Self-citationHomocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,368
Selhub, J. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.217 · Cited by 1,186
Self-citationGoldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
Self-citationParks, E. J., & Hellerstein, M. K. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.412 · Cited by 530
The controversy over homocysteine and cardiovascular risk
Ueland, P. M., Refsum, H., Beresford, S. A., & Vollset, S. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.324 · Cited by 517
Refsum, H., Nurk, E., David Smith, A., Ueland, P. M., Gjesdal, C. G., Bjelland, I., Tverdal, A., Tell, G. S., Nygård, O., & Vollset, S. E. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1731s · Cited by 493
Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis
Humphrey, L. L., Fu, R., Rogers, K., Freeman, M., & Helfand, M. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.11.1203 · Cited by 396
Helfand, M., Buckley, D. I., Freeman, M., Fu, R., Rogers, K., Fleming, C., & Humphrey, L. L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00010 · Cited by 382
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.163 · Cited by 373
Self-citationNew Risk Factors for Atherosclerosis and Patient Risk Assessment
Fruchart, J.-C., Nierman, M. C., Stroes, E. S. G., Kastelein, J. J. P., & Duriez, P. (2004) · Circulation · doi:10.1161/01.cir.0000131513.33892.5b · Cited by 348
Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy: A Randomized Controlled Trial
House, A. A., Eliasziw, M., Cattran, D. C., Churchill, D. N., Oliver, M. J., Fine, A., Dresser, G. K., & Spence, J. D. (2010) · JAMA · doi:10.1001/jama.2010.490 · Cited by 308
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Wilson, P. W. F., Pencina, M., Jacques, P., Selhub, J., D'Agostino, R., & O'Donnell, C. J. (2008) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.831198 · Cited by 299
“Characteristic or Vascular Event Men (n1430) Women (n1576) Age, years 46 (9) 45 ( 9 ) Systolic blood pressure, mm Hg 127 (15) 119 (17) Total cholesterol, mg/dL 207 (36) 203 (40) HDL cholesterol, mg/dL 43 (11) 54 (14) Diabetes mellitus, % 4% 1% Current smoker, % 35% 37% Blood pressure therapy, % 11% 9% Body mass index,…”
InfluentialSelf-citationThe Kidney and Homocysteine Metabolism
FRIEDMAN, A. N., BOSTOM, A. G., SELHUB, J., LEVEY, A. S., & ROSENBERG, I. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102181 · Cited by 288
Self-citationDe Bree, A., Verschuren, W. M. M., Kromhout, D., Kluijtmans, L. A. J., & Blom, H. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.599 · Cited by 282
Hoogeveen, E. K., Kostense, P. J., Jakobs, C., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2000) · Circulation · doi:10.1161/01.cir.101.13.1506 · Cited by 273
Oxidative imbalance in patients with mild cognitive impairment and Alzheimer’s disease
GUIDI, I., GALIMBERTI, D., LONATI, S., NOVEMBRINO, C., BAMONTI, F., TIRITICCO, M., FENOGLIO, C., VENTURELLI, E., BARON, P., & BRESOLIN, N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.001 · Cited by 203
Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade
Honjo, K., Black, S. E., & Verhoeff, N. P. L. G. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015547 · Cited by 152
Vitamin B12, folate, homocysteine and dementia: are they really related?
Arioğul, S., Cankurtaran, M., Dağli, N., Khalil, M., & Yavuz, B. (2005) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2004.07.005 · Cited by 51
da Luz, P. L., Bertini, P. J., & Favarato, D. (2005) · Clinics · doi:10.1590/s1807-59322005000500011 · Cited by 13
Metadata
- Authors
- Bostom, A. G., Silbershatz, H., Rosenberg, I. H., Selhub, J., D'Agostino, R. B., Wolf, P. A., Jacques, P. F., & Wilson, P. W. F.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 1999-05-24
- Volume
- 159
- Issue
- 10
- Pages
- 1077
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1985850018
- Cited by
- 325
- References
- 20
- FWCI
- 17.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.